Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,209 | 35,788 | 56,662 | 3,803 | 0 |
| Marketable Securities | 21,879 | 15,251 | N/A | N/A | 0 |
| TOTAL | $74,901 | $52,031 | $57,021 | $3,823 | $0 |
| Non-Current Assets | |||||
| PPE Net | 22 | 27 | 16 | 13 | N/A |
| Other Non-Current Assets | 0 | 0 | 0 | 2,053 | 0 |
| TOTAL | $22 | $27 | $16 | $2,066 | $N/A |
| Total Assets | $74,923 | $52,059 | $57,036 | $5,889 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,798 | 1,695 | 3,330 | 3,146 | 0 |
| Accrued Expenses | 2,040 | 1,536 | 975 | 1,486 | 0 |
| Other current liabilities | N/A | N/A | N/A | 406 | 0 |
| TOTAL | $4,838 | $3,231 | $4,305 | $18,168 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,838 | $3,231 | $4,305 | $18,168 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 513 | 349 | 349 | N/A | N/A |
| Common Shares | 33 | 22 | 22 | 2 | 0 |
| Retained earnings | -92,604 | -84,270 | -76,334 | -65,230 | 0 |
| Other shareholders' equity | 162 | -32 | 0 | 0 | 0 |
| TOTAL | $70,086 | $48,828 | $52,732 | $-12,279 | $0 |
| Total Liabilities And Equity | $74,923 | $52,059 | $57,036 | $5,889 | $0 |